Skip to main content
. 2011 Sep 19;121(10):4106–4117. doi: 10.1172/JCI42754

Figure 8. Treatment of Kras+Tgfbr2KO PDAC mice with CXCR2 inhibitor decreases Ctgf expression and prolongs survival.

Figure 8

(A) Immunohistochemistry of Ctgf. Scale bar: 100 μm. (B) Survival curve of Kras+Tgfbr2KO PDAC mice treated with SB225002 vs. vehicle. Cont, control; SB, SB225002. Log-rank test demonstrated a statistically significant difference between the 2 groups (P = 0.0044).